荷兰正迈向再生医学的前沿。
The Netherlands advancing to the forefront of regenerative medicine.
作者信息
Gielen Kurt
出版信息
Stem Cells Dev. 2014 Dec;23 Suppl 1:29-31. doi: 10.1089/scd.2014.0398.
PMID:25457958
Abstract
The country, and especially Limburg, the most southern province, is making major leaps forward in the commercialization of regenerative medicine. Chemelot Campus, a major business park, is making a massive commitment with the creation of "Regeneration Street"; 50,000 m² of world leading research, development, manufacturing and innovation in regenerative medicine.
摘要
该国，尤其是最南部的林堡省，在再生医学商业化方面正取得重大进展。大型商业园区Chemelot园区正在大力投入，打造“再生街”；这里有5万平方米的世界领先的再生医学研究、开发、制造和创新空间。
相似文献
1
The Netherlands advancing to the forefront of regenerative medicine.
Stem Cells Dev. 2014 Dec;23 Suppl 1:29-31. doi: 10.1089/scd.2014.0398.
2
Centre for Commercialization of Regenerative Medicine: moving forward with regenerative medicine commercialization in Canada.
Stem Cells Dev. 2013 Dec;22 Suppl 1:85-8. doi: 10.1089/scd.2013.0358.
3
Regenerative medicine and the developing world.
PLoS Med. 2006 Sep;3(9):e381. doi: 10.1371/journal.pmed.0030381.
4
Hurdles in tissue engineering/regenerative medicine product commercialization: a pilot survey of governmental funding agencies and the financial industry.
Tissue Eng Part A. 2012 Nov;18(21-22):2187-94. doi: 10.1089/ten.TEA.2012.0186. Epub 2012 Sep 27.
5
Turning Regenerative Medicine Breakthrough Ideas and Innovations into Commercial Products.
Tissue Eng Part B Rev. 2015 Dec;21(6):560-71. doi: 10.1089/ten.TEB.2015.0068. Epub 2015 Aug 27.
6
Manufacturing road map for tissue engineering and regenerative medicine technologies.
Stem Cells Transl Med. 2015 Feb;4(2):130-5. doi: 10.5966/sctm.2014-0254. Epub 2015 Jan 9.
7
Regenerative Medicine Venturing at the University-Industry Boundary: Implications for Institutions, Entrepreneurs, and Industry.
Adv Exp Med Biol. 2018;1098:213-236. doi: 10.1007/978-3-319-97421-7_12.
8
Tissue engineering/regenerative medicine ventures should invest early in market research to understand the future market's needs.
Tissue Eng Part B Rev. 2013 Apr;19(2):97-8. doi: 10.1089/ten.TEB.2012.0728. Epub 2013 Feb 19.
9
Regenerative medicine: the emergence of an industry.
J R Soc Interface. 2010 Dec 6;7 Suppl 6(Suppl 6):S771-5. doi: 10.1098/rsif.2010.0348.focus. Epub 2010 Sep 15.
10
The dangers in adopting a tissue-engineering-centric agenda: a president's perspective.
J Biomed Mater Res A. 2011 Feb;96(2):273-4. doi: 10.1002/jbm.a.32967. Epub 2010 Nov 29.
引用本文的文献
1
Improving patient outcomes with regenerative medicine: How the Regenerative Medicine Manufacturing Society plans to move the needle forward in cell manufacturing, standards, 3D bioprinting, artificial intelligence-enabled automation, education, and training.
Stem Cells Transl Med. 2020 Jul;9(7):728-733. doi: 10.1002/sctm.19-0389. Epub 2020 Mar 28.
Zotero 插件